Zinc-Facilitated Enzyme Disruption: Thiazolidinediones as Potent Carbonic Anhydrase Inhibitors in Hypoxic Cancer Microenvironments
The study demonstrates that TZD derivatives possess promising characteristics as CA XII inhibitors, with favorable physicochemical properties, strong binding affinity, stable ligand-protein interactions, and acceptable safety profiles. These findings highlight their potential for further in vitro and in vivo validation, supporting the continued exploration of thiazolidinedione scaffolds in the development of targeted anticancer therapies.
Authors
- Shakti Prasad Pattanayak (ORCID: https://orcid.org/0000-0002-1629-2648)
- Gaurav Ranjan (ORCID: https://orcid.org/0000-0003-2460-2498)
- Priyashree Sunita (ORCID: https://orcid.org/0009-0007-8066-9327)
Institutions
- Cornell University (US)
- Central University of South Bihar (IN)
- Case Western Reserve University (US)
Publication Details
- Journal
- Current Cancer Drug Targets
- Published
- 2025-10-08
- DOI
- https://doi.org/10.2174/0115680096410336250918141943
- Primary Topic
- Enzyme function and inhibition
- Type
- article
- Field-Weighted Citation Impact
- 0.00